Skip to main content
. 2023 Aug 28;9(4):399–406. doi: 10.1136/svn-2023-002428

Table 1.

The optimal PRSs associated with risks of stroke and its subtypes in the training sets

Outcomes Method PRS source* No of variants ORSD (95% CI) P value Note
Any stroke (N=7412 pairs)
Previous study PGS002259 448 1.13 (1.09 to 1.16) 1.44×10–11
C+T GCST005838 (p=1×10-6, r2=0) 38 1.11 (1.07 to 1.14) 1.90×10–9
LDpred GCST005838 (ρ=0.01, Ref=1KGP-EAS) 1 017 531 1.14 (1.10 to 1.18) 3.38×10–14 Optimal
Ischaemic stroke (N=3844 pairs)
Previous study PGS000039 1 563 569 1.07 (1.01 to 1.12) 0.012
C+T GCST90018864 (p=0.02, r2=0.8) 32 158 1.18 (1.13 to 1.24) 3.55×10–11 Optimal
LDpred GCST90018864 (ρ=0.01, Ref=1KGP-EUR) 1 017 672 1.17 (1.11 to 1.23) 1.46×10–9
Intracerebral haemorrhage (N=4296 pairs)
C+T GCST90018870 (p=0.001, r2=0.2) 1326 1.09 (1.04 to 1.14) 1.37×10–4
LDpred GCST90018870 (ρ=0.1, Ref=1KGP-EUR) 1 017 664 1.10 (1.05 to 1.15) 3.09×10–5 Optimal
Subarachnoid haemorrhage (N=359 pairs)
C+T GCST90018703 (p=0.4, r2=0) 7899 1.25 (1.06 to 1.47) 9.21×10–3 Optimal
LDpred GCST90018923 (ρ=0.01, Ref=1KGP-EUR) 1 017 665 1.15 (0.98 to 1.35) 0.096

The current table only displays the optimal PRS obtained from different strategies (previous study, C+T and LDpred) for each disease outcome. The detailed results of all PRSs can be found in online supplemental table 7.

*'PGS’ indicates the index in the PGS Catalogue. ‘GCST’ indicates the index in the GWAS Catalogue. The information in brackets is the parameter used for developing the PRS.

C+T, clumping and thresholding; EAS, East Asian; EUR, European; 1KGP, 1000 Genomes Project (Phase 3); PRS, polygenic risk score; Ref, reference population.